Microbiological overview of Achromobacter spp. As a potential infectious agent Review Article
Article Sidebar
Main Article Content
Abstract
Introduction: Achromobacter is a genus that has been gaining importance among rare and opportunistic nosocomial pathogens in the last decade, its case reports are increasing, hence the importance of reviewing the state of the art about these microorganisms. Methods: we included studies that analysed the microbiological aspects of the genus and its relationship with infections in humans, which were accessed by means of a systematic search of the information in the Pubmed database carried out on 15 September 2022; selection bias was reduced with respect to the exclusion criteria (studies in animals, articles that explore other genera and not Achromobacter, articles that explore Achromobacter unrelated to infections in humans). Results: The search yielded 92 articles of which 49 met the inclusion criteria. Conclusion: is a ubiquitous, opportunistic pathogen in humans, causing nosocomial infections, with intrinsic resistance to a broad spectrum of antimicrobials.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
INVESTIGATIO es de acceso abierto y el contenido está disponible de manera gratuita a través de su sitio web: http://revistas.uees.edu.ec/index.php/IRR/.
Para reforzar nuestra política de acceso abierto, la revista INVESTIGATIO se publica bajo una licencia Creative Commons Reconocimiento-No Comercial 4.0 Internacional (CC-BY-NC 4.0), la cual permite compartir (copiar y redistribuir el material en cualquier medio o formato) y adaptar (remezclar, transformar y crear a partir del material), bajo la condición de que se den los créditos correspondientes y no se haga uso comercial de los materiales.
References
Al-Asadi, S. A., Al-Kahachi, R. E. S., Alwattar, W. M. A., Bootwala, J., & Sabbah, M. A. (2022). Genomic Insights into Achromobacter mucicolens IA Antibiotic Resistance. Microbiology Spectrum, 10(2), e0191621. doi: 10.1128/spectrum.01916-21
Amoureux, L., Bador, J., & Neuwirth, C. (2019). Achromobacter xylosoxidans Infections after Prostate Biopsies, France, 2014. Emerging Infectious Diseases, 25(11), 2158-2159. doi: 10.3201/eid2511.161487
Amoureux, L., Sauge, J., Sarret, B., Lhoumeau, M., Bajard, A., Tetu, J., … Neuwirth, C. (2019). Study of 109 Achromobacter spp. Isolates from 9 French CF centres reveals the circulation of a multiresistant clone of A. xylosoxidans belonging to ST 137. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 18(6), 804-807. doi: 10.1016/j.jcf.2019.04.005
Aoyama, S., Masaki, A., Sakamoto, Y., Takino, H., Murase, T., Ohshima, K., … Inagaki, H. (2018). Achromobacter Infection Is Rare in Japanese Patients with Pulmonary B-cell Lymphoma. Internal Medicine (Tokyo, Japan), 57(6), 789-794. doi: 10.2169/internalmedicine.9430-17
Bates, A. S., Natarajan, M., & Reddy, R. V. (2018). Achromobacter xylosoxidans in idiopathic cystic bronchiectasis. BMJ Case Reports, 11(1). doi: 10.1136/bcr-2015-211610
Biernat, M. M., & Wróbel, T. (2021). Bacterial Infection and Non-Hodgkin B-Cell Lymphoma: Interactions between Pathogen, Host and the Tumor Environment. International Journal of Molecular Sciences, 22(14). doi: 10.3390/ijms22147372
Caverly, L. J., Spilker, T., Kalikin, L. M., Stillwell, T., Young, C., Huang, D. B., & LiPuma, J. J. (2019). In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens. Antimicrobial Agents and Chemotherapy, 64(1). doi: 10.1128/AAC.01595-19
Chan, H. T., Ku, H., Low, Y. P., Brown, T., Batinovic, S., Kabwe, M., … Tucci, J. (2020). Characterization of Novel Lytic Bacteriophages of Achromobacter marplantensis Isolated from a Pneumonia Patient. Viruses, 12(10). doi: 10.3390/v12101138
Coward, A., Kenna, D. T. D., Woodford, N., & Turton, J. F. (2020). Structured surveillance of Achromobacter, Pandoraea and Ralstonia species from patients in England with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 19(3), 388-393. doi: 10.1016/j.jcf.2019.11.005
Damar-Çelik, D., Nørskov-Lauritsen, N., & Özbek-Çelik, B. (2020). Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis. Journal of Global Antimicrobial Resistance, 22, 713-717. doi: 10.1016/j.jgar.2020.06.001
de Castro, R. L., Lima, N. de A., Lino, D. O. da C., & Melgar, T. A. (2020). A Rare Case of Non-Prosthetic Aortic Valve Infectious Endocarditis Caused by Achromobacter xylosoxidans. The American Journal of Case Reports, 21, e923031. doi: 10.12659/AJCR.923031
Dupont, C., Jumas-Bilak, E., Doisy, C., Aujoulat, F., Chiron, R., & Marchandin, H. (2018). Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment. Applied and Environmental Microbiology, 84(23). doi: 10.1128/AEM.01739-18
Esposito, S., Pisi, G., Fainardi, V., & Principi, N. (2021). What is the role of Achromobacter species in patients with cystic fibrosis? Frontiers in Bioscience (Landmark Edition), 26(12), 1613-1620. doi: 10.52586/5054
Fleurbaaij, F., Henneman, A. A., Corver, J., Knetsch, C. W., Smits, W. K., Nauta, S. T., … Hensbergen, P. J. (2018). Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans. Scientific Reports, 8(1), 8181. doi: 10.1038/s41598-018-26079-z
Fluit, A. C., Bayjanov, J. R., Aguilar, M. D., Benaissa-Trouw, B., Tunney, M. M., Westreenen, M. van, … Ekkelenkamp, M. B. (2022). Taxonomic position, antibiotic resistance and virulence factors of clinical Achromobacter isolates. Frontiers in Bioscience (Scholar Edition), 14(2), 9. doi: 10.31083/j.fbs1402009
Gabrielaite, M., Bartell, J. A., Nørskov-Lauritsen, N., Pressler, T., Nielsen, F. C., Johansen, H. K., & Marvig, R. L. (2021). Transmission and Antibiotic Resistance of Achromobacter in Cystic Fibrosis. Journal of Clinical Microbiology, 59(4). doi: 10.1128/JCM.02911-20
Gabrielaite, M., Nielsen, F. C., Johansen, H. K., & Marvig, R. L. (2021). Achromobacter spp. Genetic adaptation in cystic fibrosis. Microbial Genomics, 7(7). doi: 10.1099/mgen.0.000582
Garrigos, T., Neuwirth, C., Chapuis, A., Bador, J., & Amoureux, L. (2021). Development of a database for the rapid and accurate routine identification of Achromobacter species by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(1), 126.e1-126.e5. doi: 10.1016/j.cmi.2020.03.031
Garrigos, Thomas, Dollat, M., Magallon, A., Chapuis, A., Varin, V., Bador, J., … Amoureux, L. (2021). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Rapid Detection of Isolates Belonging to the Epidemic Clones Achromobacter xylosoxidans ST137 and Achromobacter ruhlandii DES from Cystic Fibrosis Patients. Journal of Clinical Microbiology, 59(10), e0094621. doi: 10.1128/JCM.00946-21
Ghali, M. G. Z., & Kim, M. J. (2020). Trimethoprim-sulfamethoxazole-induced hyponatremia in an elderly lady with Achromobacter xylosoxidans pneumonia: Case report and insights into mechanism. Medicine, 99(33), e20746. doi: 10.1097/MD.0000000000020746
Holgersen, M. G., Marthin, J. K., Johansen, H. K., & Nielsen, K. G. (2021). A retrospective review of Achromobacter species and antibiotic treatments in patients with primary ciliary dyskinesia. Chronic Respiratory Disease, 18, 14799731211061600. doi: 10.1177/14799731211061600
Isler, B., Kidd, T. J., Stewart, A. G., Harris, P., & Paterson, D. L. (2020). Achromobacter Infections and Treatment Options. Antimicrobial Agents and Chemotherapy, 64(11). doi: 10.1128/AAC.01025-20
Janarthanan, M., Gollapalli, S., & Sankaranarayanan, S. (2019). Achromobacter xylosoxidans Sepsis Unveiling X-linked Agammaglobulinemia Masquerading as Systemic-onset Juvenile Idiopathic Arthritis. Indian Pediatrics, 56(5), 423-425.
Le Goff, M., Vastel, M., Lebrun, R., Mansuelle, P., Diarra, A., Grandjean, T., … Durand, E. (2022). Characterization of the Achromobacter xylosoxidans Type VI Secretion System and Its Implication in Cystic Fibrosis. Frontiers in Cellular and Infection Microbiology, 12, 859181. doi: 10.3389/fcimb.2022.859181
Lebeaux, D., Merabishvili, M., Caudron, E., Lannoy, D., Van Simaey, L., Duyvejonck, H., … Vaneechoutte, M. (2021). A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient. Viruses, 13(1). doi: 10.3390/v13010060
Marion-Sanchez, K., Pailla, K., Olive, C., Le Coutour, X., & Derancourt, C. (2019). Achromobacter spp. healthcare associated infections in the French West Indies: A longitudinal study from 2006 to 2016. BMC Infectious Diseases, 19(1), 795. doi: 10.1186/s12879-019-4431-3
Menetrey, Q., Sorlin, P., Jumas-Bilak, E., Chiron, R., Dupont, C., & Marchandin, H. (2021). Achromobacter xylosoxidans and Stenotrophomonas maltophilia: Emerging Pathogens Well-Armed for Life in the Cystic Fibrosis Patients’ Lung. Genes, 12(5). doi: 10.3390/genes12050610
Okoliegbe, I. N., Hijazi, K., Cooper, K., Ironside, C., & Gould, I. M. (2020). Longitudinal Surveillance and Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Achromobacter Species from Cystic Fibrosis Patients. Antimicrobial Agents and Chemotherapy, 64(11). doi: 10.1128/AAC.01467-20
Papalia, M., Steffanowski, C., Traglia, G., Almuzara, M., Martina, P., Galanternik, L., … Radice, M. (2020). Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina. Revista Argentina de Microbiologia, 52(1), 13-18. doi: 10.1016/j.ram.2019.03.004
Park, J. H., Lee, E. K., Lee, S. Y., Kim, D. Y., & Kim, J. Y. (2018). Recurrent Endophthalmitis Caused by Achromobacter xylosoxidans: Importance of Aggressive Surgical Removal of Capsular Bag. Korean Journal of Ophthalmology : KJO, 32(2), 160-162. doi: 10.3341/kjo.2017.0143
Pedersen, M. G., Olesen, H. V., Jensen-Fangel, S., Nørskov-Lauritsen, N., & Wang, M. (2018). Colistin resistance in Pseudomonas aeruginosa and Achromobacter spp. Cultured from Danish cystic fibrosis patients is not related to plasmid-mediated expression of mcr-1. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society, 17(2), e22-e23. doi: 10.1016/j.jcf.2017.12.001
Pérez Barragán, E., Sandino Pérez, J., Corbella, L., Orellana, M. A., & Fernández-Ruiz, M. (2018). Achromobacter xylosoxidans bacteremia: Clinical and microbiological features in a 10-year case series. Revista Espanola De Quimioterapia: Publicacion Oficial De La Sociedad Espanola De Quimioterapia, 31(3), 268-273.
Pickrum, A. M., DeLeon, O., Dirck, A., Tessmer, M. H., Riegert, M. O., Biller, J. A., … Frank, D. W. (2020). Achromobacter xylosoxidans Cellular Pathology Is Correlated with Activation of a Type III Secretion System. Infection and Immunity, 88(7). doi: 10.1128/IAI.00136-20
Pickrum, A. M., Riegert, M. O., Wells, C., Brockman, K., & Frank, D. W. (2022). The In Vitro Replication Cycle of Achromobacter xylosoxidans and Identification of Virulence Genes Associated with Cytotoxicity in Macrophages. Microbiology Spectrum, 10(4), e0208322. doi: 10.1128/spectrum.02083-22
Pongchaikul, P., Santanirand, P., Antonyuk, S., Winstanley, C., & Darby, A. C. (2020). AcGI1, a novel genomic island carrying antibiotic resistance integron In687 in multidrug resistant Achromobacter xylosoxidans in a teaching hospital in Thailand. FEMS Microbiology Letters, 367(14). doi: 10.1093/femsle/fnaa109
Price, E. P., Soler Arango, V., Kidd, T. J., Fraser, T. A., Nguyen, T.-K., Bell, S. C., & Sarovich, D. S. (2020). Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp. Microbial Genomics, 6(7). doi: 10.1099/mgen.0.000406
Ridderberg, W., Jensen Handberg, K., & Nørskov-Lauritsen, N. (2020). Prevalence of hypermutator isolates of Achromobacter spp. From cystic fibrosis patients. International Journal of Medical Microbiology : IJMM, 310(2), 151393. doi: 10.1016/j.ijmm.2020.151393
Rolston, K. V. I., Gerges, B. Z., Reitzel, R., Shelburne, S. A., Aitken, S. L., Raad, I. I., & Prince, R. A. (2022). In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer. Journal of Global Antimicrobial Resistance, 29, 1-6. doi: 10.1016/j.jgar.2022.01.020
Sandri, A., Veschetti, L., Saitta, G. M., Passarelli Mantovani, R., Carelli, M., Burlacchini, G., … Malerba, G. (2022). Achromobacter spp. Adaptation in Cystic Fibrosis Infection and Candidate Biomarkers of Antimicrobial Resistance. International Journal of Molecular Sciences, 23(16). doi: 10.3390/ijms23169265
Shortridge, D., Arends, S. J. R., Streit, J. M., & Castanheira, M. (2021). Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens. Antimicrobial Agents and Chemotherapy, 65(11), e0126421. doi: 10.1128/AAC.01264-21
Steffanowski, C., Papalia, M., Iriarte, A., Langleib, M., Galanternik, L., Gutkind, G., … Radice, M. (2022). Full characterization of plasmids from Achromobacter ruhlandii isolates recovered from a single patient with cystic fibrosis (CF). Revista Argentina de Microbiologia, 54(1), 3-8. doi: 10.1016/j.ram.2021.01.005
Tavassoli, S., Gunn, D., Williams, O. M., & Darcy, K. (2018). The successful treatment of a multidrug-resistant Achromobacter xylosoxidans corneal ulcer with topical meropenem. BMJ Case Reports, 2018, bcr-2018-225163. doi: 10.1136/bcr-2018-225163
Veschetti, L., Sandri, A., Patuzzo, C., Melotti, P., Malerba, G., & Lleo, M. M. (2021). Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients. Microbial Genomics, 7(7). doi: 10.1099/mgen.0.000606
Warner, N. C., Bartelt, L. A., Lachiewicz, A. M., Tompkins, K. M., Miller, M. B., Alby, K., … van Duin, D. (2021). Cefiderocol for the Treatment of Adult and Pediatric Patients With Cystic Fibrosis and Achromobacter xylosoxidans Infections. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 73(7), e1754-e1757. doi: 10.1093/cid/ciaa1847
Zhou, X., Wang, L., Wu, S., Yang, Y., Guo, Y., Shen, S., … Yang, F. (2022). Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria. Journal of Global Antimicrobial Resistance, 30, 123-126. doi: 10.1016/j.jgar.2022.06.003
Zhu, Z., Xu, J., & He, F. (2021). Genomic and phylogenetic analysis of multidrug-resistant Achromobacter xylosoxidans ST273 strain MTYH1 co-carrying bla(OXA-114g) and bla(CARB-2) recovered from a wound infection in China. Journal of Global Antimicrobial Resistance, 25, 110-113. doi: 10.1016/j.jgar.2021.03.008